FDA Adverse Event Malfunction Summary report: N

HEMOCHRON JR SIGNATURE SYSTEM

MDR report key: 2057974 · Received March 9, 2011

Report

Report Number
2248721-2011-00033
Event Type
Malfunction
Date Received
March 9, 2011
Report Date
February 10, 2011
Manufacturer
INTERNATIONAL TECHNIDYNE CORP.
Product Code
JPA
PMA / PMN Number
K940401
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). MANUFACTURER/EVALUATION/INVESTIGATION CURRENTLY IN PROCESS. ACTUAL DEVICE INVOLVED IN COMPLAINT WAS EVALUATED. CUSTOMER COMPLAINT COULD NOT BE CONFIRMED. NO CONCLUSION CAN BE DRAWN. ITC HAS REQUESTED ALL DATA REQUIRED FOR FORM 3500A.

Description of Event or Problem · 1

PATIENT 2 OF 2. HEALTHCARE PROFESSIONAL REPORTS HEMOCHRON JR SIGNATURE SYSTEM DISCREPANCY SINCE SWITCHING CUVETTE LOT. PT/INR 6.2, LAB PT/INR 2.6. PATIENT TREATMENT WAS BASED ON THE LAB PT/INR. THE PATIENT'S THERAPEUTIC RANGE IS 2.0-3.0. PATIENT IS ON ANTICOAGULATION REGIMEN OF BOTH COUMADIN AND LOW MOLECULAR WEIGHT HEPARIN. ALL LIQUID QUALITY CONTROL TESTS HAVE BEEN ACCEPTABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HEMOCHRON JR SIGNATURE SYSTEM JPA INTERNATIONAL TECHNIDYNE CORP. HEM JR-CUVET FG H0JPT081

Patients

Seq Age Sex Outcome Treatment
1 COUMADIN| LOVENOX